Owens & Minor (NYSE:OMI) Reaches New 12-Month Low – Here’s What Happened

Owens & Minor, Inc. (NYSE:OMI)’s share price reached a new 52-week low during trading on Monday . The company traded as low as $8.39 and last traded at $8.51, with a volume of 137753 shares. The stock had previously closed at $8.65.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on OMI. Barclays reduced their price target on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. UBS Group dropped their target price on Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Robert W. Baird cut their target price on shares of Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 4th. Finally, Citigroup reduced their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Owens & Minor currently has a consensus rating of “Hold” and an average price target of $18.50.

Owens & Minor Trading Down 2.6 %

The firm has a market capitalization of $632.38 million, a P/E ratio of -12.74, a PEG ratio of 0.25 and a beta of 0.48. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The firm has a 50 day moving average of $13.18 and a 200-day moving average of $13.99.

Insider Activity

In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of Owens & Minor stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the transaction, the chief financial officer now owns 130,822 shares in the company, valued at $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 3.59% of the company’s stock.

Institutional Investors Weigh In On Owens & Minor

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Foundry Partners LLC acquired a new stake in shares of Owens & Minor during the third quarter valued at about $5,238,000. Charles Schwab Investment Management Inc. raised its holdings in Owens & Minor by 13.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company’s stock valued at $30,127,000 after buying an additional 276,807 shares during the last quarter. Algert Global LLC boosted its position in Owens & Minor by 189.4% during the 3rd quarter. Algert Global LLC now owns 276,438 shares of the company’s stock worth $4,337,000 after buying an additional 180,922 shares during the period. Connor Clark & Lunn Investment Management Ltd. grew its holdings in Owens & Minor by 374.2% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 223,074 shares of the company’s stock worth $3,500,000 after acquiring an additional 176,029 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Owens & Minor by 68.4% during the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after purchasing an additional 152,999 shares during the period. Institutional investors own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.